Godman B - Search Results

1

Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.

McGinn D, Godman B, Lonsdale J, Way R, Wettermark B, Haycox A. McGinn D, et al. Among authors: godman b. Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):73-85. doi: 10.1586/erp.09.73. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20121565

2

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies.

Godman B, Haycox A, Schwabe U, Joppi R, Garattini S. Godman B, et al. Pharmacoeconomics. 2008;26(2):91-8. doi: 10.2165/00019053-200826020-00001. Pharmacoeconomics. 2008. PMID: 18198930 Review.

3

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

Wettermark B, Godman B, Andersson K, Gustafsson LL, Haycox A, Bertele V. Wettermark B, et al. Among authors: godman b. Pharmacoeconomics. 2008;26(7):537-50. doi: 10.2165/00019053-200826070-00001. Pharmacoeconomics. 2008. PMID: 18563945 Review.

4

Enhancing the rational use of new medicines across European health care systems.

Garattini S, Bertele' V, Godman B, Haycox A, Wettermark B, Gustafsson LL; Piperska Group. Garattini S, et al. Among authors: godman b. Eur J Clin Pharmacol. 2008 Dec;64(12):1137-8. doi: 10.1007/s00228-008-0537-z. Eur J Clin Pharmacol. 2008. PMID: 18688606 No abstract available.

5

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Godman B, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83. doi: 10.1586/14737167.9.1.65. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19371180 Review.

6

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.

Godman B, Schwabe U, Selke G, Wettermark B. Godman B, et al. Pharmacoeconomics. 2009;27(5):435-8. doi: 10.2165/00019053-200927050-00010. Pharmacoeconomics. 2009. PMID: 19586083 No abstract available.

7

Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.

Wettermark B, Pehrsson A, Juhasz-Haverinen M, Veg A, Edlert M, Törnwall-Bergendahl G, Almkvist H, Godman B, Granath F, Bergman U. Wettermark B, et al. Among authors: godman b. Qual Prim Care. 2009;17(3):179-89. Qual Prim Care. 2009. PMID: 19622268

8

Potential savings without compromising the quality of care.

Norman C, Zarrinkoub R, Hasselström J, Godman B, Granath F, Wettermark B. Norman C, et al. Among authors: godman b. Int J Clin Pract. 2009 Sep;63(9):1320-6. doi: 10.1111/j.1742-1241.2009.02129.x. Int J Clin Pract. 2009. PMID: 19691615

9

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences.

Wettermark B, Godman B, Jacobsson B, Haaijer-Ruskamp FM. Wettermark B, et al. Among authors: godman b. Appl Health Econ Health Policy. 2009;7(3):137-47. doi: 10.1007/BF03256147. Appl Health Econ Health Policy. 2009. PMID: 19799468

10

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.

Godman B, Burkhardt T, Bucsics A, Wettermark B, Wieninger P. Godman B, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):475-84. doi: 10.1586/erp.09.43. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19817531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters